Skip NavigationSkip to Content

An engineered cell line with a hRpn1-attached handle to isolate proteasomes

  1. Author:
    Negi,Hitendra
    Osei Amponsa,Vasty
    Ibrahim, Bishoy
    Evans, Christine N
    Sullenberger, Catherine
    Loncarek,Jadranka
    Chari,Raj
    Walters,Kylie
  2. Author Address

    Protein Processing Section, Structural Biophysics Laboratory, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Frederick, MD 21702, USA., Genome Modification Core, Frederick National Laboratory for Cancer Research, Frederick, MD 21702, USA., Cancer Innovation Laboratory, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Frederick, MD 21702, USA., Protein Processing Section, Structural Biophysics Laboratory, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Frederick, MD 21702, USA. Electronic address: kylie.walters@nih.gov.,
    1. Year: 2023
    2. Date: Jun 22
    3. Epub Date: 2023 06 22
  1. Journal: The Journal of Biological Chemistry
    1. Pages: 104948
  2. Type of Article: Article
  3. Article Number: 104948
  1. Abstract:

    Regulated protein degradation in eukaryotes is performed by the 26S proteasome, which contains a 28-subunit hollow core particle (CP) within which proteolysis occurs, and a 19-subunit regulatory particle (RP) that binds, processes, and translocates substrates to the CP. In addition to its intrinsic subunits, myriad proteins interact with the proteasome transiently, including factors that assist and/or regulate its degradative activities. Efforts to identify proteasome-interacting components and/or to solve its structure have relied on over-expression of a tagged plasmid, establishing stable cell lines, or laborious purification protocols to isolate native proteasomes from cells. Here, we describe an engineered human cell line, derived from colon cancer HCT116 cells, with a biotin handle on the RP subunit hRpn1/PSMD2 for purification of 26S proteasomes. A 75-residue sequence from Propionibacterium shermanii that is biotinylated in mammalian cells was added following a TEV protease cut site at the C-terminus of hRpn1. We tested and found that 26S proteasomes can be isolated from this modified HCT116 cell line by using a simple purification protocol. More specifically, biotinylated proteasomes were purified from the cell lysates by using neutravidin agarose resin and released from the resin following incubation with TEV protease. The purified proteasomes had equivalent activity in degrading a model ubiquitinated substrate, namely ubiquitinated p53, compared to commercially available bovine proteasomes that were purified by fractionation. In conclusion, advantages of this approach to obtain 26S proteasomes over others is the simple purification protocol and that all cellular proteins, including the tagged hRpn1 subunit, remain at endogenous stoichiometry. Copyright © 2023 The Authors. Published by Elsevier Inc. All rights reserved.

    See More

External Sources

  1. DOI: 10.1016/j.jbc.2023.104948
  2. PMID: 37354974
  3. PII : S0021-9258(23)01976-2

Library Notes

  1. Fiscal Year: FY2022-2023
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel